Craig Bennison

Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States

C. Simons, Daniel C. Malone, Michael Wang et al. · Journal of Medical Economics · 2021 · 23 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +16

Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole

Craig Bennison, Stephanie Stephens, Bénédicte Lescrauwaet et al. · Journal of Market Access & Health Policy · 2016 · 16 citations · Full text

Medicine, Ophthalmology, Surgery +12

Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland

Michaela Barbier, Nicholas Durno, Craig Bennison et al. · The European Journal of Health Economics · 2021 · 16 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making

Sebastian Gonzalez‐McQuire, Meletios Α. Dimopoulos, Katja Weisel et al. · MDM Policy & Practice · 2019 · 14 citations · Full text

Medicine, Biostatistics, Hematology +17

Long-Term Outcomes of Eladocagene Exuparvovec Compared with Standard of Care in Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency: A Modelling Study

C. Simons, Wuh‐Liang Hwu, Rongrong Zhang et al. · Advances in Therapy · 2023 · 10 citations · Full text

Pharmacy, Neuroscience, Gene Therapy +13